DEC 23, 2016 1:42 PM PST

Men Sue J&J Over Breast Growth Side Effect

WRITTEN BY: Xuan Pham

A Johnson & Johnson drug approved for the treatment of a handful of mood or mental disorders is coming under fire for causing unwanted male breast development.

Image credit: Pixabay.com

Risperdal was approved in the US market in the early 1990s. It is prescribed mainly as an antipsychotic, for the treatment of bipolar disorder and schizophrenia. It is also prescribed as a mood stabilizer for irritability in people with autism.

However, among the drug’s side effects, patients say there another one that they were not told about: gynecomastia, or development of male breasts. Specifically a group of men who took the drug in the early 2000’s say that gynecomastia was not disclosed to them clearly.

In total, the new lawsuit will represent 13,000 patients who Jason Itkin, the lead lawyer, say were “injured by the drug.”

Among the patients is Eddie Bible. Bible recounts having taken Risperdal for the treatment of anxiety and bipolar disorder when he was 13. "They put me on this Risperdal. The doctors said, 'Well, Risperdal was helping some.' To me, it didn't really help, because a year and a half later, I had gynecomastia."

Bible’s side effects were so bad that he thought at one point he would have to get a training bra. He also vividly recalls being publicly shamed for his appearance. "I'd go to the locker room, and people would point and stare. Everybody picking on you for being a boy with boobs. ... It's just ... depressing,” said Bible.

It wasn’t until 2006 that the manufacturers disclosed gynecomastia as a side effect of Risperdal. And that was too little too late for Bible and the thousands of others who had already taken the drug without full knowledge of how the drug would affect their bodies. "If I knew what the side effects would be of the medication, I would have never taken it," Bible said

"Looking back on it, I feel like an experiment," he said.

This is not the first time Risperdal has been in the legal spotlight. In 2012, Johnson & Johnson settled a multimillion dollar lawsuit for promoting the drug can treat dementia without sufficient evidence or approval.

For Bible and others like him, suing Johnson & Johnson for disfigurement goes beyond monetary compensation. They want to make sure that a drug company that helps treat conditions in kids live up to the highest standards so as to avoid future damages, the likes of which they’ve had to endure.

However, the road to getting compensation may be harder than expected. Earlier this week, a Pennsylvania judge ruled to dismiss the case on the grounds of "inadequate" expert testimony. The decision is currently being appealed.

Additional sources: CNN

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 03, 2020
Cancer
Improving Diagnostics in Breast Cancer
AUG 03, 2020
Improving Diagnostics in Breast Cancer
Diagnostics is one of the essential tools in a physician’s toolkit. A good diagnostic test can identify whether a ...
AUG 12, 2020
Cancer
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
AUG 12, 2020
Comparing Nivolumab and Pembrolizumab in the Treatment of Lung Cancer
Since the 1940s, chemotherapy has been a primary treatment option for cancer. The late 20th century brought a new type o ...
SEP 01, 2020
Clinical & Molecular DX
Scalp Implants Monitor Epileptic Seizures
SEP 01, 2020
Scalp Implants Monitor Epileptic Seizures
Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can mon ...
OCT 01, 2020
Cardiology
Investigating Inflammation in Coronary Artery Bypass Grafts
OCT 01, 2020
Investigating Inflammation in Coronary Artery Bypass Grafts
The heart is a vital part of the body that can last one hundred years, yet even a small change can cause massive consequ ...
OCT 01, 2020
Clinical & Molecular DX
Presenting the World's Smallest Ultrasound Detector
OCT 01, 2020
Presenting the World's Smallest Ultrasound Detector
It’s smaller than a human cell, but the diminutive size of the newly-developed ultrasound detector is by no means ...
NOV 16, 2020
Clinical & Molecular DX
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
NOV 16, 2020
How the CRISPR-based COVID Microlab Can Intercept the Pandemic
The demand for diagnostic technologies to track COVID-19 infections and control community spread of the disease has only ...
Loading Comments...